Trial intelligence / Profile preview

Ultrasound-guided ozone vs corticosteroid vs prolotherapy injections for shoulder tendinopathy

IRCT20151017024572N17Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
May 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of medical ozonated water, triamcinolone, lidocaine and dextrose in shoulder tendinopathy (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Visual Analogue Scale and Shoulder Pain and Disability Index. Started May 2019; status: completed.

02

Drugs

medical ozonated watertriamcinolonelidocainedextrose
03

Conditions

shoulder tendinopathy

Beyond the preview

Go deeper on IRCT20151017024572N17.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20151017024572N17.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call